Clinicopathological and Molecular Data and Outcomes of MET Inhibitors in NSCLC With MET Exon 14 Skipping Mutations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
ESMO Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
ESMO Open 2024 Aug 29;9(9)103680, ML Reale, F Passiglia, F Cappuzzo, G Minuti, M Occhipinti, A Bulotta, A Delmonte, C Sini, D Galetta, E Roca, G Pelizzari, D Cortinovis, E Gariazzo, S Pilotto, F Citarella, E Bria, P Muscolino, D Pozzessere, A Carta, D Pignataro, L Calvetti, F Leone, M Banini, C Di Micco, E Baldini, A Favaretto, U Malapelle, S Novello, G Pasello, M TiseoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.